Skip to content

Assessing the effects of an educational intervention for chronic disease management in rural China

Vertical integrated service model: an educational intervention for chronic disease for patients and healthcare professionals in rural China

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13319989
Enrollment
1980
Registered
2017-04-04
Start date
2015-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optimising care for adult patients with type 2 diabetes or primary hypertension Nutritional, Metabolic, Endocrine

Interventions

The project is an interventional study conducted in three counties in Jiangsu Province, China. The selection of intervention and control groups is done by the local (township level) health bureaus. Th

Sponsors

Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with type 2 diabetes (FBG =7.0 mmol/l, and/or 2hPBG =11.1 mmol/l) or primary hypertension (SBP =140mmHg, and/or DBP =90mmHg) and has been on medications for more than one month 2. Aged 35-75 3. Lived in the intervention/control areas for more than two years (no records of moving within the last year) 4. Has no plan of moving from the intervention/control areas or no long-term travelling plans (more than one year) 5.Has his/her records on the chronic disease management information system of township health center or village clinic, and has accepted the chronic disease service provided by township health center or village clinic 6. Willing to participate in this project and has a preferable compliance, cognition and receptivity

Exclusion criteria

Exclusion criteria: 1. Has serious complications of diabetes or hypertension (for example, diabetic foot III/IV, diabetic retinopathy IV or higher, diabetic nephropathy IV/V, hypertension III) 2. Has been diagnosed with secondary hypertension 3. Has been diagnosed with any other serious disease, such as terminal stages of cancer, AIDS, etc 4. Pregnant women or patients with psychiatric problems

Design outcomes

Primary

MeasureTime frame
For patients: 1. Physiological measures (blood glucose/glycosylated haemoglobin (HbAlC)/blood pressure), collected during the medical examination 2. Health status, measured using the generic health-related quality of life instrument EQ-5D 3. Satisfaction with health services, health insurance, understanding of diabetes, health seeking behaviour and patients’ out-of-pocket costs of care, assessed using a questionnaire Measured at baseline and follow-up (12 months after start of intervention)

Secondary

MeasureTime frame
For healthcare professionals: 1. Knowledge about the current epidemiological situation of chronic disease in their own village, assessed through a knowledge test 2. The general procedure of diagnosing and registering chronic disease, assessed through in-depth interviews 3. The chronic disease management situation before and after intervention, assessed through in-depth interviews 4. Their general perceptions about the intervention, assessed through in-depth interviews Measured at baseline and follow-up (12 months after start of intervention)

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 6, 2026